[1]
K. Musti, S. P. Yarra, K. S. Munukutla, and N. R. Kavala, “Possible Guidelines and Regulatory Issues on Biosimilars in INDIA, USA, EU”., WJPBT, vol. 10, no. 02, pp. 51–56, Oct. 2023, doi: 10.30904/j.wjpbt.2023.4601.